Lilly Reports Fourth-Quarter and Full-Year 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Eli Lilly (LLY) PT Raised to $85 at Barclays
February 1, 2017 7:58 AM ESTBarclays raised its price target on Eli Lilly (NYSE: LLY) to $85.00 (from $80.00) while maintaining a Overweight rating.
... MoreEli Lilly & Co. (LLY) Misses Q4 EPS by 2c, Sales Beat
January 31, 2017 6:26 AM ESTEli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $0.95, $0.02 worse than the analyst estimate of $0.97. Revenue for the quarter came in at $5.76 billion versus the consensus estimate of $5.55 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2017 EPS of $4.05-$4.15, versus the consensus of... More
